相关实验视频
Updated: Jun 18, 2025

11:53
Substrate Generation for Endonucleases of CRISPR/Cas Systems
Published on: September 8, 2012
27.3K
在CBASS,Pycsar,Thoeris和CRISPR抗菌体防御中进行核酸免疫信号传递
Samuel J Hobbs1,2, Philip J Kranzusch1,2
1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;
Annual review of microbiology
|July 31, 2024
概括
细菌使用核酸信号来防御菌体. 这篇综述涵盖了四个主要系统 (CBASS,Pycsar,Thoeris和CRISPR类型III),它们的信号机制和病毒逃避策略.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 细菌拥有针对细菌 (菌根) 感染的多种防御系统.
- 这些系统中的许多系统利用专门的核酸第二信使来激活效应蛋白并阻止病毒复制.
研究的目的:
- 审查四个关键抗菌体防御系统中核酸免疫信号的分子机制:CBASS,Pycsar,Thoeris和III型CRISPR免疫.
- 分析细菌抗病毒防御中的共享信号原理和系统特定策略.
- 为了比较菌体逃避策略,并讨论细菌和真核生物抗病毒免疫之间的进化联系.
主要方法:
- 在四个主要的抗菌体防御系统中对分子机制的比较分析.
- 对菌体与宿主相互作用和免疫逃避策略的最新发现的审查.
- 检查 prokaryotic 和 eukaryotic 抗病毒免疫之间的进化联系.
主要成果:
- 在菌体检测,核酸信号合成和效应器激活中确定共享的核心原则.
- 发现增强细菌免疫防御的特定系统策略.
- 宿主和病毒在其进化军备竞赛中采用的融合策略的表征.
结论:
- 核酸信号传递是细菌抗菌体防御的基本机制,在不同系统中保留了独特的特征.
- 了解这些机制,可以了解宿主病毒的共同进化和先天免疫的更广泛的情景.
- 进化链接突出了对整个生命中基于核酸的免疫的规则.
相关概念视频
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
CRISPR
50.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.2K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Homologous Recombination
50.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.4K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K

